HomeAuthorsPosts by admin

admin

1868 POSTS6 COMMENTS

Latest Pharma-News

Lynparza with abiraterone granted Priority Review in US for mCRPC

admin - August 16, 2022 0

Latest Pharma-News

Bayer Consumer Health leaders propose new principles for science-led self-care

admin - August 3, 2022 0

Latest Pharma-News

CDC host 11th International Conference on Emerging Infectious Diseases

admin - August 2, 2022 0

Latest Pharma-News

New global alliance launched to end AIDS in children by 2030

admin - August 2, 2022 0

Latest Pharma-News

Bayer acquire majority share in sustainable lower carbon oilseed producer CoverCress Inc.

admin - August 2, 2022 0

Latest Pharma-News

FDA Provides Update on Agency Response to Monkeypox Outbreak

admin - August 2, 2022 0

Latest Pharma-News

FDA Seeks to Improve Patient Communication on LASIK Benefits and Risks Through Issuance of Draft Guidance

admin - July 28, 2022 0

Latest Pharma-News

Tezspire recommended for approval in the EU by CHMP for the treatment of severe asthma

admin - July 25, 2022 0

Latest Pharma-News

FDA Details Optimized Approach for Regulatory Oversight Tools to Better Protect Public Health

admin - July 25, 2022 0

Latest Pharma-News

Echosens and Novo Nordisk announce partnership to increase awareness and advance early diagnosis of NASH

admin - July 22, 2022 0

Latest Pharma-News

FDA Provides Educational Resources for Parents and Caregivers to Support Confidence for Imported Infant Formula Products

admin - July 14, 2022 0

Latest Pharma-News

Dupixent Phase 3 trial shows positive results in children with eosinophilic esophagitis

admin - July 14, 2022 0

1...131415...156 Page 14 of 156

TOP AUTHORS

admin

1868 POSTS6 COMMENTS

OIdMIHuOdiu

0 POSTS0 COMMENTS

tintin

0 POSTS0 COMMENTS

FDA Alerts Patients of Potential to Miss Critical Safety Alerts Due to Phone Settings When Using Smartphone-Compatible Diabetes Devices

February 10, 2025

Pfizer to Showcase Advancements Across Genitourinary Cancers at ASCO GU Cancers Symposium

February 3, 2025

FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain

February 3, 2025

Johnson & Johnson investigational therapy was recently granted U.S. FDA Priority Review for the treatment of gMG

January 24, 2025

admin

TOP AUTHORS

Most Read

FDA Alerts Patients of Potential to Miss Critical Safety Alerts Due to Phone Settings When Using Smartphone-Compatible Diabetes Devices

Pfizer to Showcase Advancements Across Genitourinary Cancers at ASCO GU Cancers Symposium

FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain

Johnson & Johnson investigational therapy was recently granted U.S. FDA Priority Review for the treatment of gMG

EDITOR PICKS

Job Interview Questions for Clinical Data Management 2024

CRASH COURSE ON CLINICAL DATA MANAGEMENT

Interview Questions on Institutional Review Board(IRB)

POPULAR POSTS

How to Find Paid Clinical Trials Near You

What Is CDISC and What Are CDISC Data Standards?

What is Dechallenge, Rechallenge and Prechallenge in Clinical trials?

POPULAR CATEGORY

ABOUT US

FOLLOW US